BioSpace News Archive

Biotech Beach

Turnstone Biologics to Present at the 2024 Bank of America Securities Health Care Conference

Turnstone Biologics Corp. announced that Sammy Farah, M.B.A., Ph.D., President and Chief Executive Officer, will present at the upcoming Bank of America Securities Health Care Conference on Wednesday, May 15, 2024, in Las Vegas, Nevada.

May 8, 2024
·
1 min read
Drug Development

Prime Medicine Presents Preclinical Data Demonstrating Ability of PM359 to Efficiently, Reproducibly and Durably Correct Causative Mutation of Chronic Granulomatous Disease (CGD)

Prime Medicine, Inc. oday reported new preclinical data demonstrating the ability of its ex vivo Prime Editing program, PM359, to correct a common disease-causing mutation of chronic granulomatous disease (CGD).

May 8, 2024
·
9 min read
Recce Pharmaceuticals Granted New Patent in China for RECCE® Anti-Infectives

Recce Pharmaceuticals Ltd. today announced the China National Intellectual Property Administration has formally granted Recce a new family two patent, “ Copolymer and Method for Treatment of Bacterial Infection , ” for its anti-infectives, with expiry in 2035.

May 8, 2024
·
3 min read
Pharm Country

Lisata Therapeutics to Participate in Upcoming May 2024 Industry and Investor Events

Lisata Therapeutics, Inc. today announced that management will participate in the following events in May.

May 8, 2024
·
3 min read
Business

IMUNON Appoints Director Dr. Stacy R. Lindborg as President and CEO

IMUNON, Inc. today announced the appointment of Stacy R. Lindborg, Ph.D. as President and Chief Executive Officer, effective May 13, 2024.

May 8, 2024
·
6 min read
Biotech Beach

ONCOTELIC PRESENTING AT BIOPHARMA NEXUS CONFERENCE SAN DIEGO 2024

Oncotelic Therapeutics, Inc (OTCQB:OTLC) announced today its presentation at Biopharma Nexus Conference.

May 8, 2024
·
4 min read
Policy

QULIPTA™ (atogepant) Now Approved by Health Canada for the Preventive Treatment of Chronic Migraine in Adults

AbbVie announced that Health Canada has approved QULIPTA for the prevention of migraine in adults who have at least four migraine days per month.

May 8, 2024
·
5 min read
Business

VolitionRx Limited Schedules First Quarter 2024 Earnings Conference Call and Business Update

VolitionRx Limited announced it will host a conference call on Tuesday, May 14 at 8.30 a.m. U.S. Eastern Time to discuss its financial and operating results for the first quarter 2024, in addition to providing a business update.

May 8, 2024
·
2 min read
Business

Alcyone Therapeutics Announces Appointment of Dr. Norbert Riedel as Chairman of the Board and Dr. Kathrin Meyer as Chief Scientific Officer and Head of Research & Development

Alcyone Therapeutics announces appointments of Norbert Riedel, Ph.D., a skilled and experienced biopharmaceutical executive, as the Chairman of its Board of Directors, and Kathrin Meyer, Ph.D., a leader in development and clinical translation of genetic therapies for the central nervous system, as Alcyone’s new Chief Scientific Officer and Head of R&D.

May 8, 2024
·
4 min read
Biotech Bay

BioMarin to Present at the BofA Securities 2024 Health Care Conference on Wednesday, May 15 at 10:00am PT / 1:00pm ET, in Las Vegas, NV

BioMarin Pharmaceutical Inc. announced that Alexander Hardy, President, and Chief Executive Officer of BioMarin will present at the BofA Securities 2024 Healthcare Conference on Wednesday, May 15, 2024, at 10:00am PT / 1:00pm ET, in Las Vegas, Nevada.

May 8, 2024
·
1 min read